Mirae Asset Global Etfs Holdings Ltd. Sage Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 31,380 shares of SAGE stock, worth $224,053. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,380
Previous 35,546
11.72%
Holding current value
$224,053
Previous $256,000
33.59%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SAGE
# of Institutions
189Shares Held
42MCall Options Held
301KPut Options Held
157K-
Black Rock Inc. New York, NY5.22MShares$37.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.84MShares$34.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.59MShares$32.8 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V84.46MShares$31.8 Million0.48% of portfolio
-
Rtw Investments, LP New York, NY3MShares$21.4 Million0.27% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $424M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...